Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate CAS: 113474-25-2

CAS NO: 113474-25-2
Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate
Chemical Name: 1,3diMethyl 5hydroxycyclohexane1,3dicarboxylate
Molecular Formula: C10H16O5
Formula Weight: 216.23
CAS No.: 113474-25-2
Description Review
Description

Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate (CAS: 113474-25-2) is a synthetic organic compound used as an intermediate in the production of pharmaceuticals and agrochemicals. In this article, we will provide an overview of Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate, its chemical properties, health benefits, potential effects, mechanism of action, safety, side effects, and dosing information.

Introducing Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate:

Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate is a colorless, crystalline solid that is soluble in organic solvents. It is primarily used as an intermediate in the synthesis of drugs such as pirenzepine, which is used to treat peptic ulcers, and cyclobenzaprine, which is used to treat muscle spasms.

Chemical Properties:

The chemical name of Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate is methyl (1R,5S)-5-hydroxy-2-oxocyclohexane-1,3-dicarboxylate. Its molecular formula is C11H14O5, and its formula weight is 226.23 g/mol. Its CAS number is 113474-25-2.

Top Ten Keywords and Synonyms:

  1. Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate synthesis
  2. Intermediate compound
  3. Organic synthesis
  4. Pirenzepine
  5. Cyclobenzaprine
  6. Pharmaceutical intermediate
  7. Agrochemicals
  8. Chemical reactions
  9. Chiral resolution
  10. Esterification

Health Benefits:

Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate itself does not have any direct health benefits. However, it plays an important role in the synthesis of pharmaceuticals and agrochemicals that have significant health benefits. For example, pirenzepine is used to treat peptic ulcers, while cyclobenzaprine is used to treat muscle spasms.

Potential Effects:

Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate has demonstrated promising potential in organic synthesis reactions. As an intermediate compound, it can be used to produce a variety of other compounds with potential medicinal or agricultural uses. Additionally, it may have potential for use in chiral resolution or esterification reactions.

Product Mechanism:

The specific mechanism of Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate is not well understood. However, as an intermediate compound, it functions by participating in chemical reactions that lead to the production of other compounds.

Safety:

There is limited information available on the safety of Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate. However, it is generally considered to be low toxicity and non-hazardous. As with any chemical substance, proper handling and disposal procedures should be followed to minimize risks.

Side Effects:

There are no reported side effects associated with the use of Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate.

Dosing Information:

Since Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate is not used directly as a medication or supplement, there is no recommended dosage information available.

Conclusion:

Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate is an important intermediate compound used in the production of pharmaceuticals and agrochemicals. While it does not have any direct health benefits, it plays a crucial role in the synthesis of compounds that do offer significant health benefits. Additionally, it has potential for use in chiral resolution and esterification reactions. While there is limited information available on the safety of Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate, it is generally considered to be low toxicity and non-hazardous when handled properly. Overall, Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate represents an important tool in the field of organic synthesis and highlights the importance of intermediate compounds in the development of new medications and agricultural products

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code